Phase I trial of CX-5461, a first-in-class G-quadruplex stabilizer in patients with advanced solid tumors enriched for DNA-repair deficiencies (CCTG IND.231) - Variant Calls
收藏数据链接：
官方服务：
资源简介：
Variant Calls from Phase I trial of CX-5461, a first-in-class G-quadruplex stabilizer in patients with advanced solid tumors enriched for DNA-repair deficiencies (CCTG IND.231) See publication for methodology.
提供机构：
Zenodo创建时间：
2022-05-13
